2001 – 2005

Oral presentations:

  • Y.  Sun, R. Carroll, N.  Seyfried, M. Machluf, N. O. Schmidt, R. V. Mulkern, J. Munasinghe, P.  Black, M.  Albert, MRI Assessment of endostatin anti-angiogenesis treatment of human brain tumors in nude mice, 2002, ISMRM, Boston, MA.
  • M. Duvshani-Eshet, G. Zarbiv, K. David, M. Machluf.  Ultrasound mediated Optison-DNA complex as a new approach for gene therapy.  The 11th Annual Congress of the European Society of Gene Therapy, November 2003, Edinburgh, Scotland.
  • L. Baruch, O. Benny, B. Lorenzo A. Bikfalvi, R. S.Carroll, and M. Machluf. Polymer encapsulation as a new delivery system of PEX and PF-4 for cancer therapy.  The European Association of Hematology, Oct 2003, Ireland.
  • M. Duvshani-Eshet, G. Zarbiv, K. David, M. Machluf.  Ultrasound mediated Optison-DNA complex as a new approach for anti-angiogenic gene delivery to prostate tumor.  Israel Association for Gene Therapy, Dec 2003 Hadassah Hospital Jerusalem.
  • M. Duvshani-Eshet, M. Machluf.   Ultrasound mediated anti-Angiogenic gene delivery in prostate cancer cells. Annual Convention of the Israeli Association of Chemical Engineering, June 2003, Tel Aviv, Israel.
  • O.  Benny, R. S. Carroll, L. Bello, A. Bikfalvi, L. Baruch, M. Machluf. Biodegradable polymeric  microspheres as a new approach for the delivery of anti-angiogenic proteins, PEX and PF-447-70 for tumor therapy. The European Association of Hematology: Conference on Angiogenesis, Oct.  2003, Ireland. Awarded for full travel grant.
  • O. Benny, R. S. Carroll, L. Bello, A. Bikfalvi, L. Baruch, M. Machluf. Biodegradable polymeric microspheres as a new approach for the delivery of anti-angiogenic proteins for the treatment of glioma. The AACR/NCI/EORTC Molecular Targets and Cancer Therapeutics Conference, Nov 17-21, 2003, Boston, MA.
  • M. Duvshani-Eshet and Marcelle Machluf. Anti-angiogenic gene delivery using ultrasound in combination with Optison-DNA complex as a new approach for   tumor therapy. Third Interdisciplinary Euro-conference on Angiogenesis, 2003 Ireland.
  • M. Duvshani-Eshet and Marcelle Machluf, Anti-angiogenic gene  delivery using ultrasound in combination with Optison-DNA complex as a new approach for tumor therapy. Israeli Control Release Society. 2003, Israel. Selected for the best research award sponsoring participation in the Controlled Release Society Meeting and exposition in June 2004, Honolulu, Hawaii 2004.
  • M. Duvshani-Eshet and M. Machluf. Cell membrane bioeffects and DNA uptake analysis post therapeutic ultrasound application using new microscopy approaches. The 12th Annual Congress of the ESGT-European Society for Gene Therapy, 2004, Tampare, Finland.
  • O. Benny, R. S. Carroll, L. Bello, A. Bikfalvi, L. Baruch, M. Machluf. Microspheres releasing endogenous inhibitors of angiogenesis: a new approach for brain tumor therapy.  The 32nd Annual Meeting of the Controlled Release Society (CRS) Miami Florida 2005. Awarded for the best Pharmaceutical research paper award with full traveling and registration sponsorship
  • M. Duvshani-Eshet and M. Machluf. Anti-angiogenic gene delivery using therapeutic ultrasound – Optison™ as a new approach for prostate tumor therapy. The 32nd Annual Meeting of the Controlled Release Society (CRS), 2005 Miami Florida, USA
  • M. Duvshani-Eshet and M. Machluf. Therapeutic ultrasound gene delivery for prostate tumor: optimization and kinetic study. The 31st Annual Meeting and Exposition of the Controlled Release Society. Honolulu Hawaii, USA, 2004. Recipient of travel grant.
  • T. Bronshtein, S. Pollack and M. Machluf. Drug-delivery to HIV-infected cells. The Israeli AIDS forum, June 2005, Tel-Aviv, Israel.

Poster presentations (Machluf’s Lab students):

  • M. Duvshani-Eshet, K. David, G.  Zarbiv and M. Machluf. Anti-angiogenic gene delivery using ultrasound in combination with DNA-Optison complex as a new approach for tumor therapy. American Association of Cancer Research, November 2003, Chicago IL.
  • O. Benny and M. Machluf. Local delivery of endogenous inhibitors from PLGA microspheres inhibits glioma tumor growth, ICRS-The Israeli Chapter of the Controlled Release Society. Israel 2004.
  • O. Benny and M. Machluf. Controlled delivery of anti-angiogenic proteins from poly(lactic-co-glycolic) acid microspheres for the treatment of glioma tumor. Annual Convention of the Israeli Association of Chemical Engineering, 2003, Tel Aviv Israel.
  • O. Benny and M. MachlufControlled delivery of anti-angiogenic proteins from poly(lactic-co-glycolic) acid microspheres for the treatment of glioma tumor, ICRS- The Israeli Chapter of the Controlled Release Society, 2003, Haifa, Israel.
  • O. Benny, R. S. Carroll, L. Bello, A. Bikfalvi, L. Baruch, M. Machluf. Biodegradable polymeric microspheres as a new approach for the delivery of anti-angiogenic proteins for the treatment of glioma, The AACR/NCI/EORTC 94th Annual Meeting New Directions in Angiogenesis Research October 2003, Chicago, IL.
  • M. Duvshani-Eshet and Marcelle Machluf.   Ultrasound mediated Optison-DNA complex as a new approach for anti-antigenic gene delivery to prostate tumors. The American Association of Cancer Research, Nov 2003, Boston, USA.